In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer
Aim: Delineate structure-based inhibition of colony-stimulating factor-1 receptor (CSF1R) by small molecule CSF1R inhibitors in clinical development for target identification and potential lead optimization in cancer therapeutics since CSF1R is a novel predictive biomarker for immunotherapy in cance...
Main Authors: | Zahra Azhar, Richard P. Grose, Afsheen Raza, Zohaib Raza |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-08-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/etat/Article/1002164 |
Similar Items
-
RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
by: Massimo Santoro, et al.
Published: (2020-04-01) -
Intrinsically Fluorescent Anti-Cancer Drugs
by: Md. Lutful Kabir, et al.
Published: (2022-07-01) -
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
by: Wenjing Xu, et al.
Published: (2022-12-01) -
Real‐world outcomes among patients with EGFR‐mutated non‐small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first‐line setting
by: Jon Apple, et al.
Published: (2023-06-01) -
Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review
by: Mohammad Al-Jundi, et al.
Published: (2020-07-01)